166 related articles for article (PubMed ID: 33198659)
1. Paternity in male kidney transplant recipients: a French national survey, the PATeRNAL study.
Boyer A; Lobbedez T; Ouethrani M; Thuillier Lecouf A; Bouvier N; Châtelet V; Hurault de Ligny B;
BMC Nephrol; 2020 Nov; 21(1):483. PubMed ID: 33198659
[TBL] [Abstract][Full Text] [Related]
2. Obstetric and neonatal outcome of pregnancies fathered by males on immunosuppression after solid organ transplantation.
Morken NH; Diaz-Garcia C; Reisaeter AV; Foss A; Leivestad T; Geiran O; Hervás D; Brännström M
Am J Transplant; 2015 Jun; 15(6):1666-73. PubMed ID: 25868657
[TBL] [Abstract][Full Text] [Related]
3. Outcomes of pregnancies fathered by solid-organ transplant recipients exposed to mycophenolic acid products.
Jones A; Clary MJ; McDermott E; Coscia LA; Constantinescu S; Moritz MJ; Armenti VT
Prog Transplant; 2013 Jun; 23(2):153-7. PubMed ID: 23782663
[TBL] [Abstract][Full Text] [Related]
4. Report from the National Transplantation Pregnancy Registry (NTPR): outcomes of pregnancy after transplantation.
Armenti VT; Radomski JS; Moritz MJ; Philips LZ; McGrory CH; Coscia LA
Clin Transpl; 2000; ():123-34. PubMed ID: 11512306
[TBL] [Abstract][Full Text] [Related]
5. Risk of Adverse Pregnancy Outcome After Paternal Exposure to Methotrexate Within 90 Days Before Pregnancy.
Eck LK; Jensen TB; Mastrogiannis D; Torp-Pedersen A; Askaa B; Nielsen TK; Poulsen HE; Jimenez-Solem E; Andersen JT
Obstet Gynecol; 2017 Apr; 129(4):707-714. PubMed ID: 28277353
[TBL] [Abstract][Full Text] [Related]
6. Paternal Exposure to Immunosuppressive and/or Biologic Agents and Birth Outcomes in Patients With Immune-Mediated Inflammatory Diseases.
Meserve J; Luo J; Zhu W; Veeravalli N; Bandoli G; Chambers CD; Singh AG; Boland BS; Sandborn WJ; Mahadevan U; Singh S
Gastroenterology; 2021 Jul; 161(1):107-115.e3. PubMed ID: 33744307
[TBL] [Abstract][Full Text] [Related]
7. Outcomes of pregnancies fathered by inflammatory bowel disease patients exposed to thiopurines.
Teruel C; López-San Román A; Bermejo F; Taxonera C; Pérez-Calle JL; Gisbert JP; Martín-Arranz M; Ponferrada A; Van Domselaar M; Algaba A; Estellés J; López-Serrano P; Linares PM; Muriel A
Am J Gastroenterol; 2010 Sep; 105(9):2003-8. PubMed ID: 20700117
[TBL] [Abstract][Full Text] [Related]
8. Report from the National Transplantation Pregnancy Registry (NTPR): outcomes of pregnancy after transplantation.
Armenti VT; Radomski JS; Moritz MJ; Gaughan WJ; Philips LZ; McGrory CH; Coscia LA;
Clin Transpl; 2002; ():121-30. PubMed ID: 12971441
[TBL] [Abstract][Full Text] [Related]
9. Report from the National Transplantation Pregnancy Registry: outcomes of pregnancy after transplantation.
Armenti VT; Daller JA; Constantinescu S; Silva P; Radomski JS; Moritz MJ; Gaughan WJ; McGrory CH; Coscia LA
Clin Transpl; 2006; ():57-70. PubMed ID: 18368705
[TBL] [Abstract][Full Text] [Related]
10. Exposure to Mycophenolate and Fatherhood.
Midtvedt K; Bergan S; Reisæter AV; Vikse BE; Åsberg A
Transplantation; 2017 Jul; 101(7):e214-e217. PubMed ID: 28346297
[TBL] [Abstract][Full Text] [Related]
11. Report from the national transplantation pregnancy registry (NTPR): outcomes of pregnancy after transplantation.
Armenti VT; Radomski JS; Moritz MJ; Gaughan WJ; Philips LZ; McGrory CH; Coscia LA
Clin Transpl; 2001; ():97-105. PubMed ID: 12211807
[TBL] [Abstract][Full Text] [Related]
12. Pregnancy and the kidney transplant recipient.
Vijayan M; Pavlakis M
Curr Opin Nephrol Hypertens; 2017 Nov; 26(6):494-500. PubMed ID: 28985190
[TBL] [Abstract][Full Text] [Related]
13. Pregnancies following high-dose cyclophosphamide with or without high-dose busulfan or total-body irradiation and bone marrow transplantation.
Sanders JE; Hawley J; Levy W; Gooley T; Buckner CD; Deeg HJ; Doney K; Storb R; Sullivan K; Witherspoon R; Appelbaum FR
Blood; 1996 Apr; 87(7):3045-52. PubMed ID: 8639928
[TBL] [Abstract][Full Text] [Related]
14. Birth Outcomes in Children Fathered by Men Treated with Immunosuppressant Drugs before Conception-A Danish Population-Based Cohort Study.
Egeberg A; Gislason GH; Nast A
J Invest Dermatol; 2017 Aug; 137(8):1790-1792. PubMed ID: 28433544
[No Abstract] [Full Text] [Related]
15. Further evidence that 6-MP taken by the father with IBD provides risk of congenital anomaly to the pregnancy.
Korelitz BI; Rajapakse RO
Am J Gastroenterol; 2001 Jan; 96(1):252. PubMed ID: 11197267
[No Abstract] [Full Text] [Related]
16. Pregnancy outcomes in solid organ transplant recipients with exposure to mycophenolate mofetil or sirolimus.
Sifontis NM; Coscia LA; Constantinescu S; Lavelanet AF; Moritz MJ; Armenti VT
Transplantation; 2006 Dec; 82(12):1698-702. PubMed ID: 17198262
[TBL] [Abstract][Full Text] [Related]
17. Immunosuppression and Reproductive Health After Kidney Transplantation.
Chandra A; Midtvedt K; Åsberg A; Eide IA
Transplantation; 2019 Nov; 103(11):e325-e333. PubMed ID: 31397802
[TBL] [Abstract][Full Text] [Related]
18. Pregnancy after liver transplantation: report of 8 new cases and review of the literature.
Dei Malatesta MF; Rossi M; Rocca B; Iappelli M; Giorno MP; Berloco P; Cortesini R
Transpl Immunol; 2006 Apr; 15(4):297-302. PubMed ID: 16635752
[TBL] [Abstract][Full Text] [Related]
19. Administration of mycophenolic acid is not associated with malformations in descendants from kidney transplanted males.
Lopez-Lopez I; Rodelo-Haad C; Agüera ML; Cabello-Jabalquinto R; Esquivias-Motta E; Navarro MD; Aljama P; Rodriguez-Benot A
PLoS One; 2018; 13(9):e0202589. PubMed ID: 30208043
[TBL] [Abstract][Full Text] [Related]
20. Paternal therapy with disease modifying drugs in multiple sclerosis and pregnancy outcomes: a prospective observational multicentric study.
Pecori C; Giannini M; Portaccio E; Ghezzi A; Hakiki B; Pastò L; Razzolini L; Sturchio A; De Giglio L; Pozzilli C; Paolicelli D; Trojano M; Marrosu MG; Patti F; Mancardi GL; Solaro C; Totaro R; Tola MR; De Luca G; Lugaresi A; Moiola L; Martinelli V; Comi G; Amato MP;
BMC Neurol; 2014 May; 14():114. PubMed ID: 24884599
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
